[카테고리:] FAQ

3billion does not collect identifiable information for patients’ privacy projection. Throughout the entire process, including ordering, lab work, and analysis, all tests are labeled with a unique ID. The information generated in the process is securely supervised and managed within 3billion’s server and AWS Cloud Authentication System. In September 2014, we achieved ISO27001 certification, establishing…

3billion needs the date of birth, gender, and symptoms for the most accurate, reliable results. Each patient’s genomic data is de-identified to protect patient privacy, and all information is used strictly for test purposes only.

If you wish to receive raw data for the sequencing results, Go to the portal and click ‘My tests’ -> click ‘Do you need the raw data?’If the submission is successful, a confirmation email will be sent to the email address you provided.It will take 1-2 business days to prepare the raw data.We will contact…

3billion’s Reanalysis Program is updated daily with the latest studies on variant-disease associations. We will immediately generate a report and inform you when there are significant changes. Please note as it is difficult to predict when research on the particular variant, gene, or disease will be published, we cannot predict when the reanalysis results will…

If you wish to include new symptoms for reanalysis,Go to the Portal -> My tests -> 3billion ID’s Details -> Symptoms/Detailsthen it will be automatically reflected. If you have additional symptoms other than HPO, please contact your representative or our support page. Also, if you agreed to ‘Automatic Reanalysis’ when you ordered the test, inconclusive…

If you agreed to the Reanalysis Program for undiagnosed cases when placing your order, we will reanalyze Inconclusive and Negative results with the latest studies which is updated daily.For more information, see the reanalysis page.

Secondary findings are variants that are not associated with the patient’s current symptoms but are known to potentially cause genetic diseases. The American College of Medical Genetics (ACMG) has selected 84 genes likely to cause diseases and recommends that they be reported as secondary findings. Before conducting a test, the medical professional should explain secondary…

Variants detected by 3B-GENOME or 3B-EXOME can be confirmed through 3B-VARIANT for the patient or family members.

The law prohibits non-medical institutions from providing genetic counseling to patients. We recommend patients consult their medical doctor, who is aware of the patients’ medical history and condition.

Variants found in patients are classified into five stages, according to 28 rules from the ACMG/AMP Standards and Guidelines, as follows: You can find more detailed information on variant classification in the ACMG/AMP Standards and Guidelines.